Evidence map›Paper›PMID 33649037›Full record

ArticleBMJ case reports2021

Takayasu's arteritis and secondary membranous nephropathy: an exceptional association.

Daniel Enos, Gonzalo Labarca, Mariel Hernandez, Gonzalo P Mendez

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Daniel EnosInternal Medicine, Universidad San Sebastian, Los Ángeles, Chile.ORCID http://orcid.org/0000-0001-9734-2493
Gonzalo LabarcaInternal Medicine, Complejo Asistencial Dr. Victor Rios Ruiz, Los Angeles, Chile glabarcat@gmail.com.ORCID http://orcid.org/0000-0002-0069-3420
Mariel HernandezNephrology Unit, Complejo Asistencial Dr. Victor Rios Ruiz, Los Angeles, Chile.
Gonzalo P MendezAnatomia Patologica, Pontificia Universidad Catolica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0003-4657-7107
Complejo Asistencial Sótero del Río · CLPontificia Universidad Católica de Chile · CLSan Sebastián University · CLUniversity of Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between Takayasu's arteritis and membranous nephropathy is uncommon. We present the case of a 46-year-old man with Takayasu's arteritis treated over 10 years by a multidisciplinary medical team. He had an atrophic left kidney due to arterial stenosis, with a basal creatinine of 1.59 mg/dL (140.55 µmol/l). Three years ago, he presented with full nephrotic syndrome, uncontrolled blood pressure, creatinine increases to 4.5 mg/dL (basal: 1.59 mg/dL), severe hypoalbuminaemia (1.4 g/dL) and albuminuria of 24.6 g per day. He underwent percutaneous biopsy of the right kidney that showed membranous nephropathy with negative PLA2R1 and positive IgG 1, 3 and 4 subclasses. After therapy with oral prednisone and cyclophosphamide, the patient's kidney function improved, without recurrence of disease after 3 years of follow-up. Here, we present this extremely uncommon association of Takayasu's arteritis and membranous nephropathy.

Indexed as

Glomerulonephritis, MembranousTakayasu ArteritisCyclophosphamideHumansMaleMiddle AgedNeoplasm Recurrence, LocalPrednisoneReceptors, Phospholipase A2CyclophosphamidePLA2R1 protein, humanPrednisoneReceptors, Phospholipase A2chronic renal failurenephrotic syndromevasculitis

Identifiers

PMID33649037
PMCPMC7929856
OpenAlexW3135840934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.